Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene

Augustin Brooks, M.L. Owens, John A. Sayer, M. Salzmann, Sian Ellard, Bijay Vaidya

QJM · 2011 · 10 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

A 41-year-old man was found to have high blood pressure of 220/100 mmHg during a routine health check-up for medical insurance. He was asymptomatic, and physical examination was unremarkable apart from a soft ejection systolic murmur heard loudest at the left sternal edge. Initial investigations showed serum sodium 144 mmol/l (reference range 132–144), potassium 6.0 mmol/l (3.5–5.5) and creatinine 100 μmol/l (45–120). There was no evidence of left ventricular hypertrophy on an electrocardiogram, and an echocardiography showed no abnormality apart from trivial tricuspid regurgitation. Renal ultrasound, renal perfusion scan and chest radiograph were also normal. The patient was given lifestyle advice, and was commenced on atenolol 100 mg once a day. Over the next 7 years, further antihypertensive agents—including amlodipine 10 mg, doxazosin 16 mg and lisinopril 5 mg—were gradually added. During this period, following an episode of renal colic, he was found to have a radio-opaque renal stone and was treated with lithotripsy. Despite multiple antihypertensive agents, his blood pressure was still consistently above 150/90 mmHg. In addition, his serum potassium levels, measured on several occasions, remained high between 5.8 and 6.6 mmol/l. Therefore, the patient was referred to the Endocrine outpatient clinic for further review.

References

9